Moreover, silibinin’s pre-treatment reduces the phosphorylation of signal transducer and activator of transcription 1 (STAT1) and signal transducer and activator of transcription 3 (STAT3) induced by cytokines responsible for the proliferation of A549 human lung cancer cells in vitro. The gene discussed is STAT1; the disease is lung carcinoma.